Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04197986 |
|---|---|
| Brief Title: | Study of Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations |
| First Submitted : | December 2, 2019 |
| First Submitted that Met QC Criteria : | December 12, 2019 |
| First Posted : | December 13, 2019 |
| Last Update Submitted that Met QC Criteria : | February 24, 2021 |
| Last Update Posted : | February 26, 2021 |